Bioelectronics Corp (BIEL)

[misanthrope]

Won't surprise many to see significantly growing revenues.

That's somewhat disingenuous, considering the last reported quarter showed sales barely over $100K. A quarter with $250K in revenue would represent a 100+ percent sales increase. That might be considered significant, but it's nowhere near the quarterly sales required to push the PPS to the euphoric heights often cited.

With the CE mark now pushed to May, that puts the deferred revenue out until at least Q2. Even with that, any deals currently being discussed may stretch into Q2, assuming any execute, which would likely mean resulting revenue doesn't hit until Q3. And so it goes....

While folks toss around figures like $2.5 million per quarter, BIEL is very likely looking at that for the entire year of 2020. While it would be a big step from 2019 (the last 'year of BIEL'), it is nowhere near the amount required to place the PPS to copper.

Cue '2021 the year of BIEL'.